» Articles » PMID: 35312468

Comparative Frequency of Venous Thromboembolism in Patients Admitted to the Hospital with SARS-CoV-2 Infection Versus Community-acquired Pneumonia

Overview
Specialty Pulmonary Medicine
Date 2022 Mar 21
PMID 35312468
Authors
Affiliations
Soon will be listed here.
Citing Articles

T Cell Receptor Sequences Amplified during Severe COVID-19 and Multisystem Inflammatory Syndrome in Children Mimic SARS-CoV-2, Its Bacterial Co-Infections and Host Autoantigens.

Root-Bernstein R, Churchill E, Oliverio S Int J Mol Sci. 2023; 24(2).

PMID: 36674851 PMC: 9861234. DOI: 10.3390/ijms24021335.


Complementary Sets of Autoantibodies Induced by SARS-CoV-2, Adenovirus and Bacterial Antigens Cross-React with Human Blood Protein Antigens in COVID-19 Coagulopathies.

Root-Bernstein R, Huber J, Ziehl A Int J Mol Sci. 2022; 23(19).

PMID: 36232795 PMC: 9569991. DOI: 10.3390/ijms231911500.

References
1.
Zhu N, Zhang D, Wang W, Li X, Yang B, Song J . A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020; 382(8):727-733. PMC: 7092803. DOI: 10.1056/NEJMoa2001017. View

2.
Cui S, Chen S, Li X, Liu S, Wang F . Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia. J Thromb Haemost. 2020; 18(6):1421-1424. PMC: 7262324. DOI: 10.1111/jth.14830. View

3.
Clayton T, Gaskin M, Meade T . Recent respiratory infection and risk of venous thromboembolism: case-control study through a general practice database. Int J Epidemiol. 2011; 40(3):819-27. PMC: 3147071. DOI: 10.1093/ije/dyr012. View

4.
Wichmann D, Sperhake J, Lutgehetmann M, Steurer S, Edler C, Heinemann A . Autopsy Findings and Venous Thromboembolism in Patients With COVID-19: A Prospective Cohort Study. Ann Intern Med. 2020; 173(4):268-277. PMC: 7240772. DOI: 10.7326/M20-2003. View

5.
Smeeth L, Cook C, Thomas S, Hall A, Hubbard R, Vallance P . Risk of deep vein thrombosis and pulmonary embolism after acute infection in a community setting. Lancet. 2006; 367(9516):1075-1079. DOI: 10.1016/S0140-6736(06)68474-2. View